[Elsevier] Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study |
|
This post will be closed automatically in 2026-07-01 21:52
Reward10points
|
30
Prognosis-driven reliability analysis and replacement policy optimization for two-phase continuous degradation
10
Neutron shielding: Advanced mechanisms, challenges, and material strategies
10
A rapid point-of-care test for the diagnosis of factor VIII inhibitors in hemophilia A patients
10
Development of nano ZnO loaded chitosan-sericin nano-biocomposite- a rapid homeostasis and effective wound healing agent
10
Research on the kinetics of catalyst coke formation during biomass catalytic pyrolysis: A mini review
